Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126296381 | 12629638 | 1 | I | 2013 | 20160721 | 20160808 | 20160808 | EXP | US-GLAXOSMITHKLINE-US2016105650 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126296381 | 12629638 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | UNKNOWN | 21077 | 1 | DF | INHALATION POWDER | BID | |||||
| 126296381 | 12629638 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 21077 | INHALATION POWDER | |||||||||||
| 126296381 | 12629638 | 3 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 2 PUFF(S), PRN | U | UNKNOWN | 0 | 2 | DF | ||||||
| 126296381 | 12629638 | 4 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | U | 0 | |||||||||||
| 126296381 | 12629638 | 5 | C | INCRUSE ELLIPTA | UMECLIDINIUM BROMIDE | 1 | UNK | 0 | INHALATION POWDER | ||||||||||
| 126296381 | 12629638 | 6 | C | MUCINEX | GUAIFENESIN | 1 | U | 0 | |||||||||||
| 126296381 | 12629638 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | U | 0 | |||||||||||
| 126296381 | 12629638 | 8 | C | LORATADINE. | LORATADINE | 1 | U | 0 | |||||||||||
| 126296381 | 12629638 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126296381 | 12629638 | 10 | C | OXYCODONE | OXYCODONE | 1 | U | 0 | |||||||||||
| 126296381 | 12629638 | 11 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126296381 | 12629638 | 1 | Asthma |
| 126296381 | 12629638 | 2 | Chronic obstructive pulmonary disease |
| 126296381 | 12629638 | 3 | Asthma |
| 126296381 | 12629638 | 4 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126296381 | 12629638 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126296381 | 12629638 | Ankle fracture | |
| 126296381 | 12629638 | Fall | |
| 126296381 | 12629638 | Spinal fracture | |
| 126296381 | 12629638 | Therapeutic response decreased | |
| 126296381 | 12629638 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126296381 | 12629638 | 1 | 2013 | 0 | ||
| 126296381 | 12629638 | 3 | 2013 | 0 | ||
| 126296381 | 12629638 | 5 | 20160717 | 0 |